The Cohorts · Quarterly vintage
Inception 2024-07-01 · 2.0 years held
Q3 2024 · Top 5.
On 2024-07-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q3 2024 · Top 5 · since inception
+62.7%
CAGR 28.1% annualised
S&P 500 · since inception
+40.2%
CAGR 18.7% annualised
Spread
+22.6%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | JPM | $196.96 | $5,454.22 | +2669.2% | $325.22 | +65.1% | +13.0% | Read → |
| 2 | BAC | $38.22 | $355.31 | +829.6% | $56.20 | +47.0% | +9.4% | Read → |
| 3 | OXY | $60.42 | $423.18 | +600.4% | $51.82 | -14.2% | -2.8% | Read → |
| 4 | LOW | $205.56 | $1,456.13 | +526.2% | $222.20 | +8.1% | +1.6% | Read → |
| 5 | CAT | $320.35 | $1,939.59 | +505.5% | $985.82 | +207.7% | +41.5% | Read → |
Biggest contributors
Where the cohort earned its keep.
- CAT · $320.35 → $985.82+207.7%
- JPM · $196.96 → $325.22+65.1%
- BAC · $38.22 → $56.20+47.0%
Biggest detractors
Where the protocol got it wrong.
- OXY · $60.42 → $51.82-14.2%